Course Catalog
Browse our full catalog of continuing education courses and events
Browse Courses & Events
Retina Resource
30th Annual International Congress on Hematologic Malignancies®: Focus on Leukemias, Lymphomas, and Myeloma - Learning Hub
Stay up to date with the latest advances in hematologic malignancies through the 30th Annual Interna...
Medical Crossfire®: Geographic Atrophy Uncovered: Slowing the Inevitable or Changing the Outcome? A CME-Certified Online Enduring Activity
David Eichenbaum, MD; Roger Goldberg, MD; Murtaza Adam, MD
Show Me the Data: Immunotherapy Across the Hepatobiliary Cancer Continuum—From Embolization-Eligible HCC to Advanced Biliary Tract Cancers
Ghassan Abou-Alfa, MD, JD, MBA, PhD (hc), FASCO; Laura Williams Goff, MD, MSCI, MMHC, FASCO; Amit Si...
Community Oncology Connections™: How Can We Optimize the Use of Oral SERDs in the Community Oncology Setting? Best Practices for HR+/HER2– Breast Cancer | Iowa Oncology Society
Wassim Mchayleh, MD, MBA, FACP; Trevor Feinstein, MD
Community Oncology Connections™: Enhancing Melanoma Outcomes With Intratumoral Oncolytic Immunotherapy – Strategies for the Multidisciplinary Team | Northern California
Yana G. Najjar, MD; Jack W. Erter III, MD, MMHC
Community Oncology Connections™: How Can We Optimize the Use of Oral SERDs in the Community Oncology Setting? Best Practices for HR+/HER2– Breast Cancer | New Mexico Society of Clinical Oncology
Erika P. Hamilton, MD; Katherine Sanchez, MD
Community Oncology Connections™: Immunotherapy Across the SCLC Continuum: Optimizing Treatment Pathways From Limited-Stage Through Relapsed Disease | West Virginia Oncology Society
Priya Kumar, MBBS, MS; Christine L. Hann, MD, PhD
Show Me the Data™: HER2-Mutant NSCLC in Transition—Translating Evidence to Practice
Solange Peters, MD, PhD; Enriqueta Felip, MD, PhD; Balazs Halmos, MD, MS; Xiuning Le, MD, PhD
Fred Hutch and Friends: Cancer Therapeutics in Practice in 2027: Cellular Therapies, ADCs, Bispecifics, and Beyond
April 23, 2027
Community Oncology Connections™: Bridging Academic and Community Expertise in Evidence-Based Care for Desmoid Tumors | Nevada Oncology Society
Mrinal M. Gounder, MD; Makenzi Evangelist, MD
Community Oncology Connections™: Bridging Academic and Community Expertise in Evidence-Based Care for Desmoid Tumors | Iowa Oncology Society
Ravin Ratan, MD, M.Ed; Megan Jagosky, MD
Cases and Conversations™: Coordinating Care and Enhancing Outcomes in a New Era of Pancreatic Cancer Treatment
Ben George, MBBS, MD; Rachel Klein, MSN, CRNP, AGNP-BC; Gabriel Perez Schwartz, MSN, FNP-BC, AOCNP
Community Oncology Connections: Navigating PD-L1–Driven Decisions and ADC Integration in Frontline mTNBC | Missouri Oncology Society
Neil M. Iyengar, MD; Ajit K. Bisen, MD, MBA
Medical Crossfire®: Responding to Injection Burden: Rethinking Anti-VEGF Therapy in Retinal Disease
Carl D. Regillo, MD; Deepika Malik, MD; Dante J. Pieramici, MD, FASRS
Community Oncology Connections™: Immunotherapy Across the SCLC Continuum: Optimizing Treatment Pathways From Limited-Stage Through Relapsed Disease | Indiana Oncology Society
Benjamin Scheier, MD; Christine L. Hann, MD, PhD
Advances in™ Pulmonary Arterial Hypertension: Navigating the Emerging Treatment Landscape With Clinical Insights
Jean M. Elwing, MD; Hilary DuBrock, MD
Best Practices in the Diagnosis and Treatment of Amyotrophic Lateral Sclerosis (ALS)
Sabrina Paganoni, MD, PhD
Cases and Conversations: Implementing Recent Updates to Improve Outcomes for Patients With MDS
December 18, 2026
Identifying a Role for Emerging Therapies in Idiopathic Inflammatory Myopathies (IIMs)
Marinos C. Dalakas, MD, PhD, FAAN
Practical Approaches for Diagnosing SMA and Individualizing Treatment Plans
Nancy L. Kuntz, MD
AREDS3 and Beyond: The Scientific Basis for B Vitamin Nutritional Supplementation in AMD
Jeffry D. Gerson, OD, FAAO; Cecelia Koetting, OD, FAAO, DipABO; Daniel Epshtein, OD, FAAO
The Optometrist’s Role in Recognizing and Managing Ocular Toxicities from Targeted Cancer Therapies
Julia Canestraro, OD, FAAO, Dipl ABO; Asim V. Farooq, MD; Neel D. Pasricha, MD
Community Oncology Connections™: Bridging Academic and Community Expertise in Evidence-Based Care for Desmoid Tumors | Washington State Medical Oncology Society
Mrinal M. Gounder, MD; Megan Jagosky, MD
Optimizing Presbyopia Management: Evidence-Based Selection and Patient-Centered Use of Pharmacologic Therapies
Mile Brujic, OD, FAAO; Melissa Barnett, OD, FAAO, FSLS, FBCLA; Tracy Swartz, OD, MS, FAAO
Cases and Conversations: Next-Generation Pathology Advances in Biomarker-Guided NSCLC—From Testing Strategies to Treatment Selection
Lyudmila Bazhenova, MD, FASCO; Michelle Afkhami, MD; Igor Odintsov, MD; Soo-Ryum (Stewart) Yang, MD
Project ECHO®: Innovations in Acute Myeloid Leukemia – Integrating the Latest Advances in Targeted Therapies to Improve Patient Outcomes
Webinar Series
Community Oncology Connections™: Immunotherapy Across the SCLC Continuum: Optimizing Treatment Pathways From Limited-Stage Through Relapsed Disease | Illinois Regional Program
Benjamin Scheier, MD; Christine L. Hann, MD, PhD
Community Oncology Connections™: Immunotherapy Across the SCLC Continuum: Optimizing Treatment Pathways From Limited-Stage Through Relapsed Disease | Tennessee Oncology Practice Society
Jack W. Erter III, MD, MMHC; Anne Chiang, MD, PhD
Live Tumor Board: Decoding Neuroendocrine Neoplasms—Practical Advances in Diagnostics, Emerging Treatments, and Real-World Management
Aman Chauhan, MD, MBBS; Connie Li, MSN, AOCNP; Simron Singh, MD, MPH, FRCPC
Increasing Awareness of Therapeutic Options for Thymidine Kinase 2 Deficiency (TK2d)
Michio Hirano, MD; Mary Kay Koenig, MD; Zarazuela Zolkipli-Cunningham, MBChB, MRCP
Cases and Conversations: Redefining EP-NEC Diagnosis and Management—Integrating DLL3 Into Pathology Practice
Deyali Chatterjee, MD; J. Randolph Hecht, MD; Jonathan Strosberg, MD; Sarah E. Umetsu, MD, PhD
Community Oncology Connections™: Immunotherapy Across the SCLC Continuum: Optimizing Treatment Pathways From Limited-Stage Through Relapsed Disease | Alabama Regional Program
Benjamin Scheier, MD; Christine L. Hann, MD, PhD
Integrating COVID-19 Prevention Into Everyday Primary Care Practice
Charles P. Vega, MD, FAAFP; William P. Hanage, PhD; Ruth Carrico, PhD, DNP, APRN, FNP-C, CIC, FSHEA,...
Acute Pain Management in Primary Care: Evidence-Based Decisions for Everyday Practice
Javier Morales, MD, FACP, FACE; Jeffrey A. Gudin, MD; Charles E. Argoff, MD
Community Oncology Connections: Navigating PD-L1–Driven Decisions and ADC Integration in Frontline mTNBC | New Mexico Society of Clinical Oncology
Neil M. Iyengar, MD; Richard Zelkowitz, MD
Tumor Board: Enhancing Pathologic Identification and Diagnostic Precision in Low-Grade Serous Ovarian Cancer
Teri A. Longacre, MD; Oliver Dorigo, MD, PhD; Pei Hui, MD, PhD
Community Practice Connections™: Immunotherapy Across the SCLC Continuum: Optimizing Treatment Pathways From Limited-Stage Through Relapsed Disease
Anne Chiang, MD, PhD; Christine L. Hann, MD, PhD; Jacob Sands, MD
Treatment Optimization in the Evolving Anti-VEGF Era
Carl Danzig, MD, FASRS; Sruthi Arepalli, MD; Priya Vakharia, MD, FASRS
Community Oncology Connections: Navigating PD-L1–Driven Decisions and ADC Integration in Frontline mTNBC | Louisiana Oncology Society
Sarah M. Tolaney, MD, MPH; Parth Khade, MD
23rd Annual Meeting of the International Society of Gastrointestinal Oncology
Tanios S. Bekaii-Saab, MD; Eileen M. O’Reilly, MD, FASCO
BURST CME™ Activity 5: Oral SERDs in Early-Stage HR+/HER2– Breast Cancer: Emerging Evidence and Clinical Implications
Erica L. Mayer, MD, MPH; Erika P. Hamilton, MD
Precision Vision: Integrating Mechanistic Insight and Clinical Strategy in ADC-Associated Ocular Toxicity
Neel Pasricha, MD; Asim V. Farooq, MD; Susana Campos, MD, MPH
















































